• Quantification and standardization of physiological assays became central, with colorimetric and titrimetric methods converted into reproducible biostatistical variables; micro-scale gasometric protocols and comprehensive statistical tables reinforced measurement reliability and comparability across laboratories [1], [2], [6], [8], [11].

• Parametric modeling of biological risk through dosage–mortality and time–mortality curves crystallized time-to-event thinking, linking exposure intensity and duration to mortality via smooth distributional forms and tabulations—foundational for bioassay, toxicology, and pharmacological inference [2], [3], [15].

• Consolidation of the classical statistical inference paradigm—sampling distributions, test criteria, estimation theory, and analysis of variance—provided a unified toolkit to interrogate biomedical data, with general treatments enabling application to diverse populations and study designs [2], [5], [16], [17], [19].

• A shift from univariate summaries to joint analysis of multiple measurements drove early multivariate biostatistics, exploiting correlation structure, vector representations, and multi-sample frameworks to extract signal from high-dimensional clinical and biological assays [7], [9], [13], [18].

• Rigorous sampling theory extended from laboratory to field biology, coupling probabilistic sampling with biodiversity and population estimation; species–individual relationships and quadrat designs exemplified how sampling underpinned ecological inference and conservation-relevant decisions [2], [10], [12], [17].